Mikko Jalanko1, Heikki Väänänen2, Mika Tarkiainen3, Petri Sipola3, Pertti Jääskeläinen3, Kirsi Lauerma4, Tiina Laitinen5, Tomi Laitinen5, Mika Laine1, Tiina Heliö1, Johanna Kuusisto6, Matti Viitasalo1. 1. Department of Cardiology, Heart and Lung Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland. 2. Department of Neuroscience and Biomedical Engineering, Aalto University, Espoo, Finland. 3. Department of Radiology, Kuopio University Hospital, Kuopio, Finland. 4. Department of Radiology, Helsinki University Hospital, Helsinki, Finland. 5. Department of Clinical Physiology, Kuopio University Hospital, Kuopio, Finland. 6. Centre for Medicine and Clinical Research, University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland.
Abstract
BACKGROUND: Hypertrophic cardiomyopathy (HCM) is characterized by ventricular repolarization abnormalities and risk of ventricular arrhythmias. Our aim was to study the association between the phenotype and ventricular repolarization dynamics in HCM patients. METHODS: HCM patients with either the MYBPC3-Q1061X or TPM1-D175N mutation (n = 46) and control subjects without mutation and hypertrophy (n = 35) were studied with 24-hr ambulatory ECG recordings by measuring time intervals of rate-adapted QT (QTe), maximal QT, and T-wave apex to wave end (TPE) intervals and the QTe/RR slope. Findings were correlated to specified echocardiographic and cardiac magnetic resonance imaging (CMRI) findings. RESULTS: Rate-adapted QTe interval was progressively longer in HCM patients with decreasing heart rates compared to control subjects (p = 0.020). The degree of hypertrophy correlated with measured QTe values. HCM patients with maximal wall thickness higher than the mean (20.6 mm) had longer maximum QTe and median TPE intervals compared to control subjects and HCM patients with milder hypertrophy (p < 0.001 and p = 0.014, respectively). HCM patients with late gadolinium enhancement (LGE) on CMRI had steeper QTe/RR slopes compared to HCM patients without LGE and control subjects (p = 0.044 and p = 0.001, respectively). LGE was an independent predictor of QTe/RR slope (p = 0.023, B = 0.043). CONCLUSION: Dynamics of ventricular repolarization in HCM are affected by hypertrophy and fibrosis. LGE may confer an independent effect on QT dynamics which may increase the arrhythmogenic potential in HCM.
BACKGROUND:Hypertrophic cardiomyopathy (HCM) is characterized by ventricular repolarization abnormalities and risk of ventricular arrhythmias. Our aim was to study the association between the phenotype and ventricular repolarization dynamics in HCM patients. METHODS: HCM patients with either the MYBPC3-Q1061X or TPM1-D175N mutation (n = 46) and control subjects without mutation and hypertrophy (n = 35) were studied with 24-hr ambulatory ECG recordings by measuring time intervals of rate-adapted QT (QTe), maximal QT, and T-wave apex to wave end (TPE) intervals and the QTe/RR slope. Findings were correlated to specified echocardiographic and cardiac magnetic resonance imaging (CMRI) findings. RESULTS: Rate-adapted QTe interval was progressively longer in HCM patients with decreasing heart rates compared to control subjects (p = 0.020). The degree of hypertrophy correlated with measured QTe values. HCM patients with maximal wall thickness higher than the mean (20.6 mm) had longer maximum QTe and median TPE intervals compared to control subjects and HCM patients with milder hypertrophy (p < 0.001 and p = 0.014, respectively). HCM patients with late gadolinium enhancement (LGE) on CMRI had steeper QTe/RR slopes compared to HCM patients without LGE and control subjects (p = 0.044 and p = 0.001, respectively). LGE was an independent predictor of QTe/RR slope (p = 0.023, B = 0.043). CONCLUSION: Dynamics of ventricular repolarization in HCM are affected by hypertrophy and fibrosis. LGE may confer an independent effect on QT dynamics which may increase the arrhythmogenic potential in HCM.
Authors: Andrea Orosz; István Baczkó; Viktória Nagy; Henriette Gavallér; Miklós Csanády; Tamás Forster; Julius Gy Papp; András Varró; Csaba Lengyel; Róbert Sepp Journal: Can J Physiol Pharmacol Date: 2015-06-12 Impact factor: 2.273
Authors: Minna Ala-Kopsala; Heikki Ruskoaho; Juhani Leppäluoto; Leila Seres; Reka Skoumal; Miklos Toth; Ferenc Horkay; Olli Vuolteenaho Journal: Clin Chem Date: 2005-02-17 Impact factor: 8.327
Authors: Raymond H Chan; Barry J Maron; Iacopo Olivotto; Michael J Pencina; Gabriele Egidy Assenza; Tammy Haas; John R Lesser; Christiane Gruner; Andrew M Crean; Harry Rakowski; James E Udelson; Ethan Rowin; Massimo Lombardi; Franco Cecchi; Benedetta Tomberli; Paolo Spirito; Francesco Formisano; Elena Biagini; Claudio Rapezzi; Carlo Nicola De Cecco; Camillo Autore; E Francis Cook; Susie N Hong; C Michael Gibson; Warren J Manning; Evan Appelbaum; Martin S Maron Journal: Circulation Date: 2014-08-05 Impact factor: 29.690
Authors: K Sakata; M Shimizu; H Ino; M Yamaguchi; H Terai; K Hayashi; M Kiyama; T Hayashi; M Inoue; H Mabuchi Journal: Heart Date: 2003-08 Impact factor: 5.994
Authors: Barry J Maron; Joseph J Doerer; Tammy S Haas; David M Tierney; Frederick O Mueller Journal: Circulation Date: 2009-02-16 Impact factor: 29.690
Authors: Iwona Cygankiewicz; Wojciech Zareba; Rafael Vazquez; Jesus Almendral; Antoni Bayes-Genis; Miquel Fiol; Mariano Valdes; Carlos Macaya; Jose R Gonzalez-Juanatey; Juan Cinca; Antoni Bayes de Luna Journal: J Cardiovasc Electrophysiol Date: 2008-06-28
Authors: Anthony J Kanai; Elisa M Konieczko; Robert G Bennett; Chrishan S Samuel; Simon G Royce Journal: Mol Cell Endocrinol Date: 2019-02-14 Impact factor: 4.102
Authors: Ali Riza Demir; Ömer Celik; Samet Sevinç; Begüm Uygur; Serkan Kahraman; Emre Yilmaz; Mete Cemek; Yilmaz Onal; Mehmet Erturk Journal: Ann Noninvasive Electrocardiol Date: 2019-06-01 Impact factor: 1.468
Authors: Mikko Jalanko; Heikki Väänänen; Mika Tarkiainen; Petri Sipola; Pertti Jääskeläinen; Kirsi Lauerma; Tiina Laitinen; Tomi Laitinen; Mika Laine; Tiina Heliö; Johanna Kuusisto; Matti Viitasalo Journal: Ann Noninvasive Electrocardiol Date: 2018-07-04 Impact factor: 1.468